These include severe abdominal pain, persistent vomiting with inability to tolerate fluids, visual changes (especially for people with diabetes and existing retinopathy), signs of allergic reaction (rash, difficulty breathing, facial swelling), right upper quadrant pain with fever or jaundice (possible gallbladder disease), or symptoms of thyroid tumors (neck mass, hoarseness, difficulty swallowing)
Additional monitoring of lithium levels may be necessary, especially during the initiation and dose escalation phases
Whilst GLP-1 receptor agonists are generally well-tolerated, patients should be aware of warning signs that require prompt medical attention
Under the Dietary Supplement Health and Education Act (DSHEA), supplements are not required to undergo pre-market approval for efficacy
Role of fatty acids -oxidation in the metabolic interactions between organs
Exciting direction if clinical outcomes and safety hold up